Harvard Bioscience (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International.As quoted in the press release:Simultaneous to the acquisition of DSI, the Company entered into a credit facility with Cerberus Business Finance,The post Harvard Bioscience Completes Acquisition of Data Sciences International appeared first on Investing News Network.